Mutations in the NF-kappaB signaling pathway: implications for human disease

G Courtois1, T D Gilmore

  • 1INSERM U697, Hôpital Saint-Louis, Paris, France.

Oncogene
|October 31, 2006
PubMed

Insights

Mutations in the nuclear factor-kappa B (NF-kappaB) pathway cause various diseases. This review details how NF-kappaB pathway genetic alterations contribute to inflammation, immunodeficiency, and cancer pathology.

Area of Science:

  • Molecular Biology
  • Genetics
  • Immunology

Background:

  • The nuclear factor-kappa B (NF-kappaB) signaling pathway is crucial for regulating genes involved in cell proliferation, survival, stress response, immunity, and inflammation.
  • Dysregulation of the NF-kappaB pathway is implicated in numerous human and animal diseases, particularly those linked to chronic inflammation, immunodeficiency, and cancer.

Purpose of the Study:

  • To review human diseases associated with mutations in core NF-kappaB signaling pathway components.
  • To discuss the molecular mechanisms by which these NF-kappaB alterations contribute to disease pathology.

Main Methods:

  • Review of human diseases linked to mutations in NF-kappaB pathway components.
  • Analysis of molecular mechanisms underlying NF-kappaB signaling alterations in disease.
  • Description of genetic diseases involving mutations in NF-kappaB modifiers, transducers, or regulatory elements.

Main Results:

  • Mutations in NF-kappaB pathway components, including germline and somatic alterations (amplifications, point mutations, deletions, translocations), are implicated in various human diseases.
  • Specific genes affected include REL, NFKB2, IKBA, CYLD, NEMO, and BCL-3.
  • Diseases can also arise from mutations affecting protein modifiers, signal transducers, or NF-kappaB binding sites.

Conclusions:

  • Genetic alterations in the NF-kappaB signaling pathway are significant contributors to human disease pathology.
  • Understanding these mutations is key to elucidating mechanisms of diseases involving inflammation, immunity, and cancer.
  • Further research into NF-kappaB pathway genetics can inform therapeutic strategies for related disorders.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...